Clinical Trials
2 trialsNCT02428764 2024-12-10
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
Phase 2 Withdrawn
NCT04833205 2021-04-20
Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Hebei Medical University
Phase 2 Unknown